Targeted drugs recognize specific markers, typically proteins, that help cancer cells grow and spread.
Breast cancer treatment has undergone a significant transformation, evolving from broad-spectrum chemotherapy to highly targeted therapies that address specific molecular subtypes. Today, treatment is largely guided by such as hormone receptors (ER/PR) and the human epidermal growth factor receptor 2 (HER2), which allow for a "precision medicine" approach. 1. Hormone (Endocrine) Therapies breast cancer drugs
Challenges and Opportunities in Metastatic Breast Cancer Treatments Tamoxifen is a cornerstone of HR+ treatment, approved
Hormone therapies are used for cancers that are hormone receptor-positive (HR+), meaning they use estrogen or progesterone to grow. These drugs either lower hormone levels or block receptors on cancer cells. 2. Targeted Therapies
Tamoxifen is a cornerstone of HR+ treatment, approved for both pre- and post-menopausal patients to reduce recurrence risk.
Drugs like Anastrozole (Arimidex) , Letrozole (Femara), and Exemestane (Aromasin) are primarily for postmenopausal women. They block the aromatase enzyme, which is necessary for making estrogen in the body. 2. Targeted Therapies